EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY 4.0

Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development

Barbara Madej, Filip Tomaszewski, Dagmara Szmajda-Krygier iD, Rafał Świechowski iD, Agnieszka Jeleń iD, Marek Mirowski iD

International Journal of Molecular Sciences · 10.09.2025 · 26 (18) · 8794

DOI: 10.3390/ijms26188794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.09.2025. Verfasst von Barbara Madej und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Faculty of Pharmacy, M…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Drug Development. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies, also called immunoglobulins, play a key role in the body’s immune response, binding to specific molecular targets. Of the five classes of antibodies, IgG has found the greatest clinical application. The article presents the mechanisms of antibody action, including interactions with FcR receptors on leukocytes, complement activation, and direct cytotoxic interactions, as well as the main methods of antibody production, which include hybridoma technology, phage display, and production using transgenic animals and their modifications, which allowed for the production of antibodies with reduced immunogenicity and increased their effectiveness and safety of use. It also characterizes various types of antibodies and presents the differences between them resulting from the structure and content of individual protein domains encoded by human genes and genes from other species. Antibodies are currently one of the most important groups of biological drugs used in the treatment of autoimmune, infectious, and neoplastic diseases. The properties of these large biomolecules and the achievements in the field of obtaining and modifying antibodies mean that they are currently the subject of many studies. New forms of antibodies, such as antibody–drug conjugates with highly potent cytotoxic agents, bispecific antibodies, and nanobodies, demonstrate an innovative approach to the treatment of cancer and autoimmune diseases. The dynamic development of the antibody market indicates its growing importance in modern pharmacy and medicine. Further research in this area may lead to the development of more effective and precise therapies, as well as to increase the safety of their use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalDrug DevelopmentHumansAnimalsAntibodies, BispecificNeoplasmsHistory, 21st CenturyHistory, 20th Century

Stichwörter der Autor:innen

antibodyantibody drug conjugates (ADCs)bispecific antibodyhybridoma technologymechanisms of actionnanobodyphage displaytransgenic animals

Substanzen

Antibodies, MonoclonalAntibodies, Bispecific

Autor:innen und Institutionen

  • Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland.

ORCID-Profile: Dagmara Szmajda-Krygier, Rafał Świechowski, Agnieszka Jeleń, Marek Mirowski

Förderung

  • Medical University of Lodz
  • Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz

Zitieren

APA

Madej, B., Tomaszewski, F., Szmajda-Krygier, D., Świechowski, R., Jeleń, A., & Mirowski, M. (2025). Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development. International Journal of Molecular Sciences, 26(18), 8794. https://doi.org/10.3390/ijms26188794

Vancouver

Madej B, Tomaszewski F, Szmajda-Krygier D, Świechowski R, Jeleń A, Mirowski M. Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development. International Journal of Molecular Sciences. 2025;26(18):8794. doi:10.3390/ijms26188794

BibTeX
@article{Madej2025,
  author = {Madej, Barbara and Tomaszewski, Filip and Szmajda-Krygier, Dagmara and Świechowski, Rafał and Jeleń, Agnieszka and Mirowski, Marek},
  title = {Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {8794},
  doi = {10.3390/ijms26188794}
}
Kostenlos starten →